Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex

PHASE2UnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

October 31, 2009

Conditions
Cystic Fibrosis
Interventions
DRUG

Azithromycin

500 mg tablets orally thrice weekly for 24 weeks

DRUG

Placebo

tablet orally thrice weekly for 24 weeks

Trial Locations (1)

M5B1W8

St. Michael's Hospital, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Pfizer

INDUSTRY

lead

Unity Health Toronto

OTHER